查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1863137

全球避孕器材市場：洞察、競爭格局及至2032年預測

Contraceptive Devices - Market Insights, Competitive Landscape, and Market Forecast - 2032
出版日期: | 出版商: DelveInsight | 英文 150 Pages | 商品交期: 2-10個工作天內

價格

避孕器材市場摘要

  • 全球避孕器市場預計將從 2024 年的 202.4583 億美元成長到 2032 年的 327.6349 億美元，反映出強勁且持續的成長。
  • 全球避孕器市場在 2025 年至 2032 年的預測期內將以 6.28% 的複合年成長率成長。
  • 全球避孕器市場成長主要受以下幾個關鍵因素驅動。首先，人們對計劃生育的認知和教育程度的提高推動了市場需求。其次，人口結構和生活方式的改變，例如生育年齡延遲和女性賦權，增加了對有效避孕解決方案的需求。第三，技術進步，例如長效可逆避孕方法（LARCs）和副作用較少的避孕產品的研發，吸引了更多使用者。最後，政府的支持措施使避孕更加便利和經濟實惠，進一步促進了市場擴張。
  • 在避孕器材市場運作的主要企業包括 Reckitt Benckiser Group PLC、Church & Dwight Co., Inc.、Organon & Co.、Bayer AG、CooperSurgical, Inc.、Mankind Pharma Ltd.、HLL Lifecare Limited、Karex Berhad、Okamoto Industries Inc.、Verkind Pharma Ltd.、HLL Lifecare Limited、Karex Berhad、Okamoto Industries Inc.、Veru Inc.、Pregnamed 和 Kcare Limited、Karex Berhad、Okamoto Industries Inc.、Veru Inc.、Pregna。
  • 由於消費者對更高避孕效果和更少副作用的需求不斷成長，北美避孕器市場正在蓬勃發展，長效可逆避孕方法（LARCs）和非荷爾蒙避孕方式越來越受到偏好。政府的利好政策，例如「平價醫療法案」（ACA），透過強制醫保覆蓋避孕產品，進一步推動了這一趨勢，提高了避孕產品的可及性。此外，數位醫療和遠端醫療服務的日益普及，也使得資訊和處方更容易取得，尤其惠及新一代消費者。
  • 根據產品類型，預計到 2024 年，保險套將佔最大的市場佔有率。

避孕器材市場成長要素

  • 計劃生育意識的提高和避孕器需求的成長正在推動市場擴張。尤其是在開發中國家和新興市場國家，計劃生育意識的提高和避孕器需求的成長是市場擴張的主要推動力。這一趨勢是由各相關人員的共同努力所推動的。
  • 政府措施：許多政府，特別是人口成長率高的國家，都已實施國家計劃生育政策和計畫。這些措施通常包括進行教育宣傳活動，向公民普及避孕對自身健康和社會經濟福祉的益處。透過提供多種避孕方法，並在某些情況下提供免費或補貼，政府積極創造並滿足了市場需求。
  • 非政府組織和公共衛生團體：非政府組織（NGO）透過提供社區教育和服務發揮重要作用，其服務對象往往是政府計畫難以充分覆蓋的邊緣化群體和農村人口。這些組織致力於消除文化和社會障礙，提供準確資訊以消除關於副作用的誤解，並培訓衛生工作者以擴大避孕選擇範圍。
  • 媒體與數位平台：透過大眾媒體、社群媒體和數位健康應用程式傳播訊息，使得性與生殖健康知識比以往任何時候都更容易獲得。這種獲取途徑的增加，增強了個人，尤其是年輕人，在健康和計劃生育方面做出知情選擇的能力，從而提高了現代避孕方法的普及率。
  • 社會經濟因素：隨著教育程度的提高和女性自主權的增強，她們更傾向於推遲或調整生育年齡，以便抓住教育和職業發展的機會。這直接增加了對有效可靠避孕措施的需求。同樣，新興市場中產階級的崛起提高了可支配收入，使他們能夠購買現代化的、通常價格較高的避孕方法，從而進一步推動了市場成長。
  • 技術進步與產品創新：技術進步和產品創新是避孕器市場成長的關鍵推動力，因為它們解決了現有的局限性，並為消費者和製造商創造了新的機會。
  • 長效可逆避孕法（LARCs）：由於其高效率、便利性和持久的避孕效果，消費者越來越偏好選擇長效可逆避孕方法，例如子宮內避孕器和皮下植入。這些避孕器無需每日或每週服用避孕藥，因此對許多使用者來說極具吸引力。
  • 新產品開發：製造商正在投資研發，以開發創新、方便用戶使用的設備，包括推出客製化保險套、新的含激素和非含激素產品，以及可與數位健康平台整合進行監測的「智慧」設備。
  • 減少副作用：新產品研發的一個重點是減少與荷爾蒙避孕相關的常見副作用，例如體重增加、頭痛和月經變化。這吸引了一群關注這些議題的新用戶群。
  • 政府措施和資金投入：許多政府，特別是人口成長率高的國家，都已實施國家計劃生育政策和計畫。這些措施通常包括進行教育宣傳活動，向公民普及避孕對自身健康和社會經濟福祉的益處。
  • 國家人口控制政策：在許多國家，尤其是在亞洲和非洲，政府實施了旨在控制和穩定人口的政策和方案。這些措施通常包括補貼或免費發放避孕藥具，從而提高避孕藥具的可近性和可負擔性。
  • 醫療保健支援：政府資助的衛生計劃，如印度的國家衛生任務，已將避孕作為公共衛生戰略的組成部分，包括培訓衛生工作者提供計劃生育諮詢和服務，包括子宮內避孕器植入。
  • 官民合作關係：政府和非政府組織擴大與私營部門合作，以擴大計劃生育服務的覆蓋範圍，並透過各種管道（包括公共診所、私人藥房和社區衛生工作者）確保在都市區和農村地區都能獲得避孕器。

避孕器材市場報告區隔

「避孕器材市場報告」全面概述了全球避孕器材市場，重點分析了關鍵趨勢、成長促進因素、課題和機會。報告按產品類型、性別、分銷管道和地區進行了詳細的市場區隔，並深入剖析了北美、歐洲和亞太等主要市場的競爭格局、監管環境和市場動態。報告詳細介紹了行業領導者的概況和最新的產品創新，為企業提供了識別市場潛力、制定策略規劃以及把握快速成長的避孕器市場新機會所需的重要數據。

避孕器，也稱為節育措施，是指旨在防止懷孕的裝置或製劑。這些裝置的作用機制多種多樣，例如形成物理屏障阻擋精子、釋放抑制排卵的激素，或在子宮內創造不利於精子和受精卵生存的環境。

全球避孕市場受多種關鍵因素驅動。首先，公共衛生宣傳活動以及人們對預防意外懷孕和性行為感染感染（STI）日益成長的關注，透過提高人們對計劃生育和生殖健康的認知和教育，推動了市場需求。其次，人口結構和生活方式的改變扮演重要角色。諸如延遲生育、女性賦權以及計劃生育責任的共同承擔等趨勢，都促使人們對有效的避孕解決方案的需求增加。第三，技術進步和產品創新，例如高效長效可逆避孕方法（LARCs，如子宮內避孕器和植入）以及副作用更少的產品的研發，吸引了更多用戶。最後，許多國家的政府支持和資金投入，透過公共衛生計畫和補貼，使避孕服務更加普及和經濟實惠，進一步推動了市場擴張。

全球避孕器材市場預計在預測期內（至 2025 年）將以約 6.8% 的強勁複合年成長率成長。

主要結構性促進因素是避孕方式持續向長效可逆避孕方法（LARC）、現代子宮內避孕器和皮下植入轉變，這些方法因其卓越的療效、便利性和臨床醫生更高的熟悉度，正在許多市場取代（或補充）短效、依賴使用者的避孕方法。採購和運輸數據顯示，LARC 的供應量同比顯著成長（儘管在近期的公共部門週期中，銅子宮內避孕器和植入的採購量也有所增加）。

聯合國人口基金及其相關夥伴關係報告稱，在 2023 年至 2024 年期間，他們支持大規模分發和政府採購。同時，分級定價和社交行銷管道正在擴大對低收入人群的覆蓋範圍，而私人診所和零售藥局則獲得了高利潤的銷售。

服務提供和取得模式正在改變人們的使用習慣。自新冠疫情爆發以來，遠端醫療、電子商務和藥屋主導的配送服務促進了人們獲取短效產品和諮詢服務，降低了停藥率，並提高了方法轉換率；同時，社區分發和自我給藥方案（例如，自行注射激素避孕藥）增強了應對供應鏈中斷的能力，並擴大了實際應用範圍。這些配送創新也減少了年輕用戶和都市區用戶使用時的阻力，他們更傾向於選擇隱密便捷的管道。

男性避孕藥研發的快速進展是整個潛在市場的曲折點。包括非荷爾蒙植入和新型口服藥物在內的多個臨床計畫在2024-2025年均報告了積極的早期結果和令人鼓舞的安全性數據。如果這些候選藥物經過關鍵性臨床試驗和法規核准，男性避孕藥有望在未來五到十年內顯著擴大市場需求，並改變避孕藥市場的模式。

最後，市場逆風和緩解因素至關重要。由於捐贈預算變化導致的採購不確定性、某些地區持續存在的未滿足需求、新型器械面臨的監管障礙以及來自價格更低的學名藥的競爭，都可能擠壓淨利率並減緩產品普及速度。相反，亞太和拉丁美洲許多國家醫療保健預算的成長、供應鏈合作的加強以及私人商業化程度的提高，代表著短期內的利好因素，即使單位成長率較低，也能維持器械價值的成長。因此，分析師應建立多種情境模型（例如，長效可逆避孕方法的基準普及率、男性避孕方法加速進入市場以及捐贈資金減少），以了解器械收入的潛在成長和下降空間。

避孕器材市場面臨許多阻礙和課題，包括宗教反對和社會禁忌等社會和文化障礙，這些障礙限制了人們對避孕的公開討論和使用。經濟和物流問題也構成課題。先進的避孕器械價格昂貴，在許多地區缺乏公共資金支持，導致很大一部分人群難以負擔，而供應鏈不完善又阻礙了分銷，使問題更加嚴重。此外，與健康相關的以及使用者自身的擔憂，例如對副作用的擔憂、缺乏準確資訊以及醫護人員培訓不足等，都可能導致避孕器械普及率低和濫用。最後，嚴格的監管流程以及過去因安全問題引發的訴訟遺留的不確定性，都可能延緩新產品的上市。

到2024年，保險套將佔全球避孕器產品市場最大的佔有率，約佔全球避孕市場的55%。其主導地位主要歸功於多種因素的綜合作用，包括其易得性、雙重防護性、消費行為。即便其他避孕方法日益普及，保險套的主導地位仍凸顯了其作為計劃生育基石產品的地位。

避孕器材市場區域分析

北美避孕器材市場趨勢

預計北美將繼續維持其作為避孕器材區域市場的主導地位，到2024年市場規模將達到91.1億美元，市佔率為41%。這一趨勢得益於技術創新，例如開發更舒適、低劑量的器材以及與數位健康平台的整合。隨著消費者對荷爾蒙類藥物副作用的認知和擔憂日益加深，對非荷爾蒙類避孕方法的需求也不斷成長。儘管女性用避孕器市場正在多元化發展，但避孕套在男性避孕器仍然佔主導地位，由於其既能預防懷孕又能預防性傳染感染的雙重功能，因此仍保持著相當大的市場佔有率。

歐洲避孕器市場趨勢

歐洲避孕器市場正經歷穩定成長，預計到2024年將達到約50億美元，年複合成長率（CAGR）為5.3%-5.4%。歐洲避孕器材市場是一個充滿活力的產業，其發展趨勢受到人們對長效可逆避孕方法（LARCs）日益成長的偏好，例如子宮內避孕器（IUD）和植入，這些方法因其高效性和便利性而廣受歡迎。此外，越來越多的人希望避免荷爾蒙藥物的副作用，因此對非荷爾蒙類避孕方法的需求不斷成長，進一步推動了這一趨勢。監管和政策支持也對市場產生了顯著影響，許多歐洲國家政府為避孕措施提供補貼和報銷，尤其是在年輕人群體中。儘管整體市場趨勢是朝著更先進的方法發展，但區域差異顯著，西歐和北歐的普及率高於東歐和南歐部分地區。

亞太地區避孕器市場趨勢

亞太地區的避孕器市場正經歷強勁成長，預計到2024年將創造約44.5億美元的收入。亞太地區人口眾多、都市化迅速，且社會經濟格局不斷變化，使其成為避孕器市場的主要成長引擎。該地區市場的發展趨勢兼顧了滿足未被滿足的需求和採用現代有效的避孕方法。

亞太地區主要市場趨勢

  • 積極的政府措施：該地區許多國家的政府，特別是像中國和印度這樣的人口大國，長期以來都制定了控制人口成長的政策。這些政府透過公共衛生宣傳活動和龐大的診所網路積極推廣計劃生育，提供補助或免費的避孕藥具。這種由上而下的支持是市場擴張的重要因素。
  • 意識提升與教育普及：教育的廣泛普及、都市化的加快以及透過媒體和網路獲取資訊的管道增多，提高了人們對性健康、生殖權利和計劃生育益處的認知。這有助於打破圍繞避孕的傳統社會和文​​化禁忌，並提高避孕措施的採用率，尤其是在年輕一代。
  • 從傳統方法到現代方法：由於對更有效的選擇的需求，以及越來越多的女性希望控制懷孕間隔而不是永久停止生育，人們逐漸從傳統的（例如，間歇性避孕和節律避孕）和永久性避孕方法轉向了現代的、可逆的方法。

避孕器材市場的主要企業

以下列出了避孕器械市場的主要企業，這些參與者總合佔最大的市場佔有率，並引領著行業趨勢。

  • Reckitt Benckiser Group PLC
  • Church & Dwight Co., Inc.
  • Organon & Co.
  • Bayer AG
  • CooperSurgical, Inc.
  • Mankind Pharma Ltd.
  • HLL Lifecare Limited
  • Karex Berhad
  • Okamoto Industries Inc.
  • Veru Inc.
  • Pregna International Limited
  • Kessel medintim GmbH
  • 其他

避孕器市場充滿活力，且呈現中等程度的分散化，既有大型跨國製藥公司，也有專業公司。拜耳和套件潔時（杜蕾斯）等公司佔了相當大的市場佔有率，尤其是在荷爾蒙和保險套領域。但由於產品類型豐富多樣，且各地區都有許多小型企業，因此市場集中度並不高。技術創新是推動市場競爭的動力，各公司競相研發新一代長效可逆避孕方法（LARCs）以及副作用更少、使用更便捷的產品。此外，非荷爾蒙類和數位健康領域的競爭也日益激烈，新參與企業和創新新進者共同主導的市場格局。

避孕器市場的最新趨勢

  • 2025 年 5 月，Famasys 的 FemBloc® 永久避孕系統獲得了 CE 標誌核准，這是一種無需手術的門診永久避孕裝置和輸送系統。
  • 2025年3月，NEXT生命科學公司宣布啟動Plan A的臨床試驗。 Plan A是一種長效、可逆、不含荷爾蒙的男性避孕藥。該產品被歸類為醫療設備，使用可注射水凝膠過濾精子，藥效永續長達10年。
  • 2025 年 2 月，Church & Dwight 的 Ribbed Ecstasy 獲得了 FDA 510(k) 許可。
  • 2025年2月，Sebela Women's Health Inc.的下一代無荷爾蒙銅子宮內避孕系統（IUS）MIUDELLA獲得美國食品藥物管理局（FDA）核准。這是40多年來美國首個核准的新型無激素子宮內避孕器。它採用柔韌的鎳鈦合金框架，銅含量不到目前市售銅子宮內避孕器的一半。
  • 2025年1月，在阿拉伯國際醫療器材展（Arab Health 2025）上，SMB公司推出了一款名為Silvee的新型銀質子宮內避孕器。此節育器採用銀質內芯，提高了耐用性和有效性，可提供長達五年的可靠避孕效果。

避孕器材市場區隔

  • 依避孕器材產品類型分類的暴露狀況
  • 保險套
  • 隔膜
  • 子宮頸帽
  • 避孕環
  • 子宮內避孕器（IUD）
  • 皮下植入避孕藥
  • 避孕裝置的性別
  • 男性避孕器
  • 女性用避孕器
  • 避孕器械的通路
  • 醫院藥房
  • 零售藥房
  • 線上藥局和D2C平台
  • 大賣場和超級市場
  • 其他
  • 避孕器械的區域趨勢
  • 北美避孕器市場
  • 美國避孕器市場
  • 加拿大避孕器市場
  • 墨西哥避孕器材市場
  • 歐洲避孕器材市場
  • 英國避孕器材市場
  • 德國避孕器材市場
  • 法國避孕器材市場
  • 義大利避孕器材市場
  • 西班牙避孕器械市場
  • 其他歐洲避孕器材市場
  • 亞太地區避孕器材市場
  • 中國避孕器材市場
  • 日本避孕器材市場
  • 印度避孕器材市場
  • 澳洲避孕器材市場
  • 韓國避孕器材市場
  • 亞太地區其他避孕器材市場
  • 世界其他地區避孕器材市場
  • 南美洲避孕器材市場
  • 中東避孕器材市場
  • 非洲避孕器市場

影響分析

美國關稅對避孕器械市場的影響分析：

美國對進口商品，特別是藥品和醫療設備相關商品加徵關稅，正對全球避孕藥市場產生重大且多方面的影響。這些關稅推高了成本，迫使主要企業尋找替代供應商，擾亂了複雜的國際供應鏈，並可能導致全球範圍內的生產延誤和產品短缺。此類經濟摩擦也可能引發其他國家的報復性關稅，進一步推高商品價格，擾亂全球貿易。跨國公司將這些增加的成本轉嫁給消費者，使得必要的避孕器，尤其是在開發中國家，變得更加難以負擔和取得。此外，關稅造成的財務不確定性可能迫使企業將研發資源重新分配到緩解供應鏈風險上，這可能會減緩創新步伐，推遲新技術在全球範圍內的推出，最終顛覆國際製造業格局。

目錄

第1章避孕器市場報告簡介

第2章避孕器市場摘要整理

  • 市場概覽

第3章避孕器市場關鍵因素分析

  • 市場促進因素
    • 提高人們對計劃生育的認知與需求
    • 技術進步與產品創新
    • 政府措施和資金
    • 人口結構和生活方式的變化
  • 市場阻礙與課題
    • 與健康相關的課題和使用者特定課題
    • 社會、文化和宗教障礙
    • 監管和物流方面的障礙
  • 市場機遇
    • 非荷爾蒙避孕與男性避孕的創新
    • 瞄準新興經濟體

第4章 影響分析

  • 美國關稅的影響分析

第5章 監理分析

  • 美國
  • 歐洲
  • 日本
  • 中國

第6章避孕器市場：波特五力分析

第7章避孕器市場評估

  • 依產品類型
  • 性別
  • 透過分銷管道
  • 地區

第8章 競爭情勢

第9章Start-Ups資金籌措與投資趨勢

第10章避孕器市場 公司及產品概況

  • Reckitt Benckiser Group PLC
  • Church & Dwight Co., Inc.
  • Organon & Co.
  • Bayer AG
  • CooperSurgical, Inc.
  • Mankind Pharma Ltd.
  • HLL Lifecare Limited
  • Karex Berhad
  • Okamoto Industries Inc.
  • Veru Inc.
  • Pregna International Limited
  • Kessel medintim GmbH

第11章：KOL視角

第12章計劃方法

第13章：關於 DelveInsight

第14章 免責聲明和聯絡我們

Product Code: DIMDCL0450

Contraceptive Devices Market Summary

  • The global contraceptive devices market is expected to increase from USD 20,245.83 million in 2024 to USD 32,763.49 million by 2032, reflecting strong and sustained growth.
  • The global contraceptive devices market is growing at a CAGR of 6.28% during the forecast period from 2025 to 2032.
  • The global contraceptive devices market is growing due to several key factors. First, increased awareness and education about family planning are boosting demand. Second, demographic and lifestyle changes, such as delayed parenthood and the empowerment of women, are driving the need for effective solutions. Third, technological advancements, including the development of long-acting reversible contraceptives (LARCs) and products with fewer side effects, are attracting more users. Lastly, supportive government initiatives are making contraception more accessible and affordable, further fueling market expansion.
  • The leading companies operating in the contraceptive devices market include Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., Organon & Co., Bayer AG, CooperSurgical, Inc., Mankind Pharma Ltd., HLL Lifecare Limited, Karex Berhad, Okamoto Industries Inc., Veru Inc., Pregna International Limited, Kessel medintim GmbH, and Others.
  • The North American contraceptive devices market is growing due to a rising preference for Long-Acting Reversible Contraceptives (LARCs) and non-hormonal options, driven by consumer demand for higher efficacy and fewer side effects. This trend is further supported by favorable government policies, such as the ACA, which has increased access by mandating insurance coverage. Additionally, the increasing integration of digital health and telehealth services is making information and prescriptions more accessible, particularly for a new generation of consumers.
  • In the product type segment of the contraceptive devices market, the condom category is estimated to account for the largest market share in 2024.

Factors Contributing to the Growth of the Contraceptive Devices Market

  • Increasing Awareness of Family Planning and Rising Demand for Contraceptives Fuelling Market Expansion: Increasing awareness of family planning and the rising demand for contraceptives are key drivers of market expansion, particularly in developing and emerging economies. This trend is fuelled by coordinated efforts from various stakeholders:
  • Government Initiatives: Many governments, especially in countries with high population growth, are implementing national family planning policies and programs. These initiatives often include educational campaigns to inform the public about the benefits of contraception for health and socioeconomic well-being. By making a wide range of contraceptive methods available and, in some cases, free or subsidized, governments are actively creating and satisfying demand.
  • NGOs and Public Health Organizations: Non-governmental organizations (NGOs) play a crucial role by providing community-based education and services, often reaching marginalized or rural populations that government programs may not fully serve. These organizations address cultural and social barriers, provide accurate information to dispel myths about side effects, and train healthcare workers to offer a wider choice of contraceptive methods.
  • Media and Digital Platforms: The proliferation of information through mass media, social media, and digital health applications is making knowledge about sexual and reproductive health more accessible than ever before. This increased access empowers individuals, especially young people, to make informed decisions about their health and family planning, leading to a higher adoption rate of modern contraceptive methods.
  • Socioeconomic Factors: As education levels rise and women gain more autonomy, there is a greater desire to delay or space pregnancies to pursue educational and career opportunities. This directly increases the demand for effective and reliable contraceptive methods. Similarly, a growing middle class in emerging markets has more disposable income to spend on modern, and often more expensive, forms of contraception, further driving market growth.
  • Technological Advancements and Product Innovation: Technological advancements and product innovation are key drivers of growth in the contraceptive devices market, as they address existing limitations and create new opportunities for both consumers and manufacturers.
  • Long-Acting Reversible Contraceptives (LARCs): There is a significant shift in consumer preference towards LARCs, such as IUDs and contraceptive implants, due to their high efficacy, convenience, and long-lasting protection. These devices reduce the need for daily or weekly attention, which is a major draw for many users.
  • Development of New Products: Manufacturers are investing in research and development to create innovative and user-friendly devices. This includes the introduction of custom-fit condoms, new hormonal and non-hormonal options, and ""smart"" devices that can be integrated with digital health platforms for monitoring.
  • Minimizing Side Effects: A key focus of new product development is to reduce common side effects associated with hormonal contraception, such as weight gain, headaches, and menstrual changes. This is attracting a new segment of users who are concerned about these issues.
  • Government Initiatives and Funding: Many governments, especially in countries with high population growth, are implementing national family planning policies and programs. These initiatives often include educational campaigns to inform the public about the benefits of contraception for health and socioeconomic well-being.
  • National Population Control Policies: In many countries, particularly in Asia and Africa, governments are implementing policies and programs aimed at population control and stabilization. These initiatives often include subsidies and free distribution of contraceptive devices, thereby increasing their accessibility and affordability.
  • Healthcare Support: Government-backed healthcare programs, like the National Health Mission in India, are making contraception an integral part of their public health strategy. This includes training healthcare workers to provide family planning counseling and services, including the insertion of IUDs.
  • Public-Private Partnerships: Governments and NGOs are increasingly collaborating with the private sector to expand the reach of family planning services, ensuring that contraceptives are available in both urban and rural areas through a variety of channels, including public clinics, private pharmacies, and community-level health workers.

Contraceptive Devices Market Report Segmentation

This contraceptive devices market report offers a comprehensive overview of the global contraceptive devices market, highlighting key trends, growth drivers, challenges, and opportunities. It covers detailed market segmentation by Product Type (Condom, Diaphragms, Cervical Cap, Vaginal Rings, Intrauterine Device (IUD), and Sub Dermal Contraceptive Implants), Gender (Male Contraceptive Devices, Female Contraceptive Devices), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and D2C Platforms, Hypermarkets and Supermarkets, and Others), and geography. The report provides valuable insights into the competitive landscape, regulatory environment, and market dynamics across major markets, including North America, Europe, and Asia-Pacific. Featuring in-depth profiles of leading industry players and recent product innovations, this report equips businesses with essential data to identify market potential, develop strategic plans, and capitalize on emerging opportunities in the rapidly growing contraceptive devices market.

A contraceptive device, also known as a form of birth control, is a device or preparation designed to prevent pregnancy. These devices work in various ways, such as creating a physical barrier to block sperm, releasing hormones to inhibit ovulation, or making the uterine environment inhospitable to sperm or fertilized eggs.

The global contraceptive devices market is growing due to several key factors. First, increased awareness and education about family planning and reproductive health, driven by public health campaigns and a greater focus on preventing unintended pregnancies and sexually transmitted infections (STIs), is boosting demand. Second, demographic and lifestyle changes are playing a major role; trends such as delayed parenthood, the empowerment of women, and an increasing emphasis on shared responsibility for family planning are driving the need for effective contraceptive solutions. Third, technological advancements and product innovation, including the development of highly effective long-acting reversible contraceptives (LARCs) like IUDs and implants, as well as products with fewer side effects, are attracting more users. Lastly, supportive government initiatives and funding in many countries are making contraception more accessible and affordable through public health programs and subsidies, further fueling market expansion.

What are the latest Contraceptive Devices Market Dynamics and Trends?

The global contraceptive devices market is projected to expand at a robust compound annual growth rate (CAGR) of approximately 6.8% during the forecast period of 2025 to 2032, driven by rising LARC uptake, broader public-sector procurement, and growing private-sector demand in APAC and LATAM.

A primary structural driver is the continuing shift toward long-acting reversible contraceptives (LARCs), modern IUDs, and subdermal implants, which are displacing (or supplementing) short-acting, user-dependent methods in many markets because of superior efficacy, convenience, and improved clinician familiarity. Procurement and shipment data show notable year-on-year increases in LARC supplies (copper IUD and implant procurement rose in recent public-sector cycles), which raises the market's value even when unit volumes are stable because LARCs command higher per-patient revenue and longer duration of protection.

Public procurement, donor programs, and government family-planning initiatives remain foundational to volume growth. Large multilateral and bilateral suppliers (including UNFPA partnerships) continue to supply billions of units of condoms and substantial volumes of implants/IUDs to low- and middle-income countries; UNFPA and related partnerships reported large-scale distribution and support for government procurement in 2023-2024, which both fills unmet need and creates visible demand that attracts manufacturers and investors. At the same time, tiered pricing and social-marketing channels are expanding reach into lower-income segments while private clinics and retail pharmacies capture higher-margin sales.

Service delivery and access models are changing the use pattern: telehealth, e-commerce, and pharmacy-led provision have made short-acting products and counselling easier to access since COVID-19, reducing discontinuation and improving method switching; meanwhile, community distribution and self-administered options (e.g., self-injectable for hormonal contraception) have hardened the resilience of supply chains against disruptions and expanded real-world uptake. These delivery innovations also lower the friction for young and urban users who prefer discreet, convenient channels.

A potential inflection point for total addressable market size is the rapid progress in male-contraception R&D. Multiple clinical programs, including non-hormonal implants and novel oral agents, reported positive early results or encouraging safety data in 2024 - 2025; if these candidates advance through pivotal trials and regulatory review, male methods could materially expand demand and shift method mixes over the next 5-10 years.

Finally, market headwinds and moderating factors matter: procurement volatility when donor budgets shift, persistent unmet need in certain geographies, regulatory hurdles for novel devices, and competition from cheaper generic options can compress margins or delay uptake. Conversely, rising health budgets in many APAC and LATAM countries, stronger supply-chain coordination, and active private-sector commercialization are near-term tailwinds that sustain growth in device value even where unit growth is incremental. Analysts should therefore model multiple scenarios (baseline adoption of LARCs, accelerated male-method entry, and donor-funding contraction) to capture the plausible upside and downside to device revenues.

The contraceptive devices market faces significant restraints and challenges, including social and cultural barriers like religious opposition and societal taboos that limit open discussion and use of contraception. Economic and logistical issues also pose a challenge, as the high cost of advanced devices and a lack of public funding in many regions make them inaccessible to large populations, compounded by poor supply chains that hinder distribution. Furthermore, health-related and user-specific concerns like perceived side effects, a lack of accurate information, and insufficient training for healthcare providers can lead to low adoption rates and incorrect usage. Finally, stringent regulatory processes and the lingering fear from past litigation over safety issues can delay the introduction of new products to the market.

Contraceptive Devices Market Segment Analysis

Contraceptive Devices Market by Product Type (Condom, Diaphragms, Cervical Cap, Vaginal Rings, Intrauterine Device (IUD), and Sub Dermal Contraceptive Implants), Gender (Male Contraceptive Devices, Female Contraceptive Devices), Distribution Channel (Hospital Pharmacy, Retail Pharmacy, Online Pharmacies and D2C Platforms, Hypermarkets and Supermarkets, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World)

By Product Type: Condom Category Dominates the Market

In 2024, the condom product type held the largest share, commanding approximately 55% of the global contraceptive devices market. This dominance is primarily attributed to a combination of factors related to accessibility, dual protection, and consumer behavior. This dominance highlights condoms as a foundational product in the family planning landscape, even as other methods gain traction.

Key Insights into Condom Market Dominance:

  • Dual Protection: Condoms are the only widely available contraceptive device that offers dual protection against both unintended pregnancy and sexually transmitted infections (STIs), including HIV. This dual benefit makes them a critical public health tool and a preferred choice for individuals who are not in monogamous relationships or who prioritize STI prevention.
  • Accessibility and Affordability: Condoms are generally the most affordable and accessible contraceptive method. They can be purchased without a prescription from a wide variety of locations, including pharmacies, supermarkets, convenience stores, and online retailers. This widespread availability, combined with their low cost, makes them a go-to option, especially in developing countries.
  • Widespread Use in Public Health Programs: Governments and NGOs worldwide actively promote and distribute condoms, often for free or at heavily subsidized prices. These public health initiatives, particularly in regions with high rates of HIV/AIDS and other STIs, contribute significantly to condom market volume and help to normalize their use.
  • User-Controlled and Non-Invasive: Unlike many other methods like IUDs or implants, condoms are non-invasive, and their use is entirely user-controlled. This gives individuals a sense of autonomy and control over their reproductive health decisions. The fact that they can be used on demand, without a long-term commitment, appeals to a wide range of consumers.
  • Product Innovation and Marketing: While condoms have been around for a long time, the market is continually innovating to improve the user experience. This includes a wide range of products with different materials (latex-free options for allergies), textures, flavors, and sizes. Sophisticated marketing campaigns also help to destigmatize their use and appeal to modern consumer preferences, particularly among young adults.

Despite the growing popularity and high effectiveness of long-acting reversible contraceptives (LARCs) like IUDs and implants, condoms' unique benefits in terms of dual protection, accessibility, and user control ensure their continued dominant position in the global market.

By Gender: Male Contraceptive Devices Dominate the Market

The dominance of male contraceptive devices, specifically male condoms, in the global market is driven by a unique combination of factors. The primary reason for their commanding 55% share of the market revenue in 2024 is their dual-purpose functionality; condoms are the only widely available contraceptive device that provides effective protection against both unintended pregnancy and sexually transmitted infections (STIs), including HIV. This makes them an essential tool for public health and a top choice for individuals seeking comprehensive protection. Furthermore, condoms are highly accessible and affordable, requiring no prescription and being sold in a vast range of retail locations, from pharmacies to convenience stores, which ensures widespread availability, especially in low-income regions.

Global public health campaigns by governments and NGOs also heavily promote and distribute condoms to combat STIs, significantly boosting sales volume. Lastly, their user-controlled and non-invasive nature appeals to consumers who prefer a method that doesn't involve long-term commitment or potential side effects associated with hormonal methods or surgical procedures. These combined factors, dual protection, accessibility, affordability, and user control, ensure that male condoms continue to dominate the contraceptive devices market, even with the rise of newer, high-tech alternatives.

By Distribution Channel: Retail Pharmacy Category Dominates the Market

Retail pharmacies maintained a dominant market share in the contraceptive devices market in 2024, holding approximately 40% of the revenue. This is primarily due to their broad geographic reach and the immediate availability of products, allowing consumers to get what they need quickly and in person. However, the online and Direct-to-Consumer (D2C) channel is growing at a robust rate. This growth is driven by consumer preferences for discretion and privacy, the convenience of ordering products from home, and the increasing integration of telehealth services for prescriptions. While retail pharmacies will remain a key channel for their established trust and physical presence, the online/D2C channel is rapidly expanding by offering a more private, convenient, and often more affordable shopping experience, suggesting a future market shaped by a hybrid of both physical and digital retail models.

Contraceptive Devices Market Regional Analysis

North America Contraceptive Devices Market Trends

North America is projected to maintain its position as the dominant regional market for contraceptive devices, with a significant market share of 41% in 2024 valued at USD 9.11 billion, driven by a growing preference for Long-Acting Reversible Contraceptives (LARCs) like IUDs and implants due to their high efficacy and convenience. This trend is supported by technological innovation, which is focused on creating more comfortable, lower-dose devices and integrating with digital health platforms. The market is also seeing a rising demand for non-hormonal options as consumers become more aware of and concerned about the side effects of hormonal methods. While the market for female devices is diversifying, the male contraceptive segment, dominated by condoms, maintains a significant share due to their dual function of preventing both pregnancy and STIs. The market is further shaped by supportive healthcare policies and a nascent but growing trend of investment in new male contraceptive research and development.

Europe Contraceptive Devices Market Trends

The Europe contraceptive devices market is experiencing steady growth, generating about USD 5 billion in 2024, growing at a CAGR of 5.3-5.4%. The European contraceptive devices market is a dynamic sector shaped by a growing preference for Long-Acting Reversible Contraceptives (LARCs), like IUDs and implants, which are gaining popularity due to their high efficacy and convenience. This trend is further fueled by a rising demand for non-hormonal options, as a segment of the population seeks to avoid the side effects of hormonal methods. The market is also heavily influenced by a supportive regulatory and policy landscape, with many European governments providing subsidies and reimbursement for contraception, particularly for young people. While the overall market is trending toward more advanced methods, there are significant regional differences, with higher adoption rates in Western and Northern Europe compared to some parts of Eastern and Southern Europe. Additionally, the increasing integration of digital and telehealth solutions is making it easier for consumers to access information and prescriptions, which is a growing driver for the market.

Asia-Pacific Contraceptive Devices Market Trends

The Asia-Pacific contraceptive devices market is experiencing robust growth, generating about USD 4.45 billion in revenue in 2024. The Asia-Pacific region is a major growth engine for the contraceptive devices market, driven by its large population, rapid urbanization, and evolving socioeconomic landscape. The market trends in this diverse region are a mix of addressing unmet needs and adopting modern, effective methods.

Key Market Trends in Asia-Pacific

  • Proactive Government Initiatives: Many governments in the region, particularly in populous countries like China and India, have long-standing policies to manage population growth. These governments actively promote family planning through public health campaigns and a vast network of health clinics that provide subsidized or free contraceptive devices. This top-down support is a major driver of market expansion.
  • Rising Awareness and Education: The increasing prevalence of education, urbanization, and access to information through media and the internet is raising awareness about sexual health, reproductive rights, and the benefits of family planning. This is helping to break down traditional social and cultural taboos surrounding contraception, leading to higher adoption rates, especially among younger generations.
  • Shift from Traditional to Modern Methods: While traditional methods (like withdrawal or rhythm) and permanent sterilization have been common, there is a gradual but significant shift toward modern, reversible methods. This is driven by a desire for more effective options and a growing number of women who want to space pregnancies rather than stop childbearing permanently.

Who are the major players in the Contraceptive Devices Market?

The following are the leading companies in the contraceptive devices market. These companies collectively hold the largest market share and dictate industry trends.

  • Reckitt Benckiser Group PLC
  • Church & Dwight Co., Inc.
  • Organon & Co.
  • Bayer AG
  • CooperSurgical, Inc.
  • Mankind Pharma Ltd.
  • HLL Lifecare Limited
  • Karex Berhad
  • Okamoto Industries Inc.
  • Veru Inc.
  • Pregna International Limited
  • Kessel medintim GmbH
  • Others

How is the competitive landscape shaping the Contraceptive Devices Market?

The competitive landscape of the contraceptive devices market is dynamic and moderately fragmented, with a mix of multinational pharmaceutical giants and specialized players. While companies like Bayer and Reckitt Benckiser (Durex) hold significant market share, particularly in the hormonal and condom segments, respectively, the market is not highly concentrated due to the variety of product types and the presence of numerous smaller, regional companies. Competition is driven by a focus on technological innovation, with companies racing to develop next-generation LARCs (Long-Acting Reversible Contraceptives) and more user-friendly products with fewer side effects. Additionally, there is a growing competitive dynamic in the non-hormonal and digital health segments, as new entrants and established players alike seek to capture market share by addressing consumer concerns about hormones and leveraging new technologies. This environment fosters a continuous cycle of product development, strategic partnerships, and mergers and acquisitions, ultimately shaping a market defined by a blend of established leaders and innovative newcomers.

Recent Developmental Activities in the Contraceptive Devices Market

  • In May 2025, Femasys received CE Mark approval for its in-office, non-surgical permanent contraception device and delivery system, FemBloc(R) Permanent Birth Control System.
  • In March 2025, NEXT Life Sciences announced the launch of clinical trials for Plan A, a long-lasting, reversible, and hormone-free male contraceptive. The product, which is classified as a medical device, uses an injectable hydrogel to filter out sperm for up to 10 years.
  • In February 2025, FDA 510(k) clearance for Church & Dwight's ribbed Ecstasy variant.
  • In February 2025, Sebela Women's Health Inc. received FDA approval for MIUDELLA, a next-generation, hormone-free copper intrauterine system (IUS). It is the first new hormone-free IUD to be approved in the U.S. in over 40 years. It uses a flexible nitinol frame and less than half the copper of the currently available copper IUD.
  • In January 2025, at Arab Health 2025, SMB Corporation unveiled the Silvee, a new silver IUD. The device features a silver core to enhance durability and effectiveness, providing up to five years of reliable contraception.

Contraceptive Devices Market Segmentation

  • Contraceptive Devices Product Type Exposure
  • Condom
  • Diaphragms
  • Cervical Cap
  • Vaginal Rings
  • Intrauterine Device (IUD)
  • Sub Dermal Contraceptive Implants
  • Contraceptive Devices Gender Exposure
  • Male Contraceptive Devices
  • Female Contraceptive Devices
  • Contraceptive Devices Distribution Channel Exposure
  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacies and D2C Platforms
  • Hypermarkets and Supermarkets
  • Others
  • Contraceptive Devices Geography Exposure
  • North America Contraceptive Devices Market
  • United States Contraceptive Devices Market
  • Canada Contraceptive Devices Market
  • Mexico Contraceptive Devices Market
  • Europe Contraceptive Devices Market
  • United Kingdom Contraceptive Devices Market
  • Germany Contraceptive Devices Market
  • France Contraceptive Devices Market
  • Italy Contraceptive Devices Market
  • Spain Contraceptive Devices Market
  • Rest of Europe Contraceptive Devices Market
  • Asia-Pacific Contraceptive Devices Market
  • China Contraceptive Devices Market
  • Japan Contraceptive Devices Market
  • India Contraceptive Devices Market
  • Australia Contraceptive Devices Market
  • South Korea Contraceptive Devices Market
  • Rest of Asia-Pacific Contraceptive Devices Market
  • Rest of the World Contraceptive Devices Market
  • South America Contraceptive Devices Market
  • Middle East Contraceptive Devices Market
  • Africa Contraceptive Devices Market

Impact Analysis

U.S. Tariff Impact Analysis on the Contraceptive Devices Market:

The implementation of U.S. tariffs on imported goods, particularly those related to pharmaceuticals and medical devices, has a significant and multifaceted impact on the global contraceptive devices market. These tariffs disrupt the complex international supply chain by increasing costs and forcing companies to find alternative suppliers, which can lead to production delays and product shortages worldwide. This economic friction can also trigger retaliatory tariffs from other countries, further raising the cost of goods and hindering global trade. As multinational companies pass these increased costs onto consumers, essential contraceptives become less affordable, particularly in developing countries. Furthermore, the financial uncertainty caused by tariffs may compel companies to divert resources from research and development toward mitigating supply chain risks, which could slow the pace of innovation and delay the launch of new technologies globally, ultimately reshaping the international manufacturing landscape.

How This Analysis Helps Clients

  • Cost Management: By understanding the tariff landscape, clients can anticipate cost increases and adjust pricing strategies accordingly, ensuring profitability.
  • Supply Chain Optimization: Clients can identify alternative sourcing options and diversify their supply chains to reduce dependency on high-tariff regions, enhancing resilience.
  • Regulatory Navigation: Expert guidance on navigating the evolving regulatory environment helps clients maintain compliance and avoid potential legal challenges.
  • Strategic Planning: Insights into tariff impacts enable clients to make informed decisions about manufacturing locations, partnerships, and market entry strategies.

Key takeaways from the contraceptive devices market report study

  • Market size analysis for the current contraceptive devices market size (2024), and market forecast for 8 years (2025 to 2032)
  • Top key product/technology developments, mergers, acquisitions, partnerships, and joint ventures happened over the last 3 years.
  • Key companies dominating the contraceptive devices market.
  • Various opportunities available for the other competitors in the contraceptive devices market space.
  • What are the top-performing segments in 2024? How these segments will perform in 2032?
  • Which are the top-performing regions and countries in the current contraceptive devices market scenario?
  • Which are the regions and countries where companies should have concentrated on opportunities for the contraceptive devices market growth in the future?

Frequently Asked Questions for the Contraceptive Devices Market

1. What is the growth rate of the contraceptive devices market?

  • The contraceptive devices market is estimated to grow at a CAGR of 6.28% during the forecast period from 2025 to 2032.

2. What is the market for contraceptive devices?

  • The contraceptive devices market was valued at USD 20,245.83 million in 2024, and is expected to reach USD 32,763.49 million by 2032.

3. Which region has the highest share in the contraceptive devices market?

  • The North American contraceptive devices market is growing due to a rising preference for Long-Acting Reversible Contraceptives (LARCs) and non-hormonal options, driven by consumer demand for higher efficacy and fewer side effects. This trend is further supported by favorable government policies, such as the ACA, which has increased access by mandating insurance coverage. Additionally, the increasing integration of digital health and telehealth services is making information and prescriptions more accessible, particularly for a new generation of consumers.

4. What are the drivers for the contraceptive devices market?

  • The global contraceptive devices market is growing due to several key factors. First, increased awareness and education about family planning are boosting demand. Second, demographic and lifestyle changes, such as delayed parenthood and the empowerment of women, are driving the need for effective solutions. Third, technological advancements, including the development of long-acting reversible contraceptives (LARCs) and products with fewer side effects, are attracting more users. Lastly, supportive government initiatives are making contraception more accessible and affordable, further fueling market expansion.

5. Who are the key players operating in the contraceptive devices market?

  • Some of the key market players operating in the contraceptive devices market include Reckitt Benckiser Group PLC, Church & Dwight Co., Inc., Organon & Co., Bayer AG, CooperSurgical, Inc., Mankind Pharma Ltd., HLL Lifecare Limited, Karex Berhad, Okamoto Industries Inc., Veru Inc., Pregna International Limited, Kessel medintim GmbH, and Others.

Table of Contents

1. Contraceptive Devices Market Report Introduction

  • 1.1 Scope of the Study
  • 1.2 Market Segmentation
  • 1.3 Market Assumption

2. Contraceptive Devices Market Executive Summary

  • 2.1 Market at Glance

3. Contraceptive Devices Market Key Factors Analysis

  • 3.1 Contraceptive Devices Market Drivers
    • 3.1.1 Rising Awareness and Demand for Family Planning
    • 3.1.2 Technological Advancements and Product Innovation
    • 3.1.3 Government Initiatives and Funding
    • 3.1.4 Demographic and Lifestyle Changes
  • 3.2 Contraceptive Devices Market Restraints and Challenges
    • 3.2.1 Health-Related and User-Specific Challenges
    • 3.2.2 Social, Cultural, and Religious Barriers
    • 3.2.3 Regulatory and Logistical Hurdles
  • 3.3 Contraceptive Devices Market Opportunity
    • 3.3.1 Innovation in Non-Hormonal and Male Contraception
    • 3.3.2 Targeting Emerging Economies

4. Impact Analysis

  • 4.1 U.S. Tariff Impact Analysis

5. Regulatory Analysis

  • 5.1 The United States
  • 5.2 Europe
  • 5.3 Japan
  • 5.4 China

6. Contraceptive Devices Market Porter's Five Forces Analysis

  • 6.1 Bargaining Power of Suppliers
  • 6.2 Bargaining Power of Consumers
  • 6.3 Threat of New Entrants
  • 6.4 Threat of Substitutes
  • 6.5 Competitive Rivalry

7. Contraceptive Devices Market Assessment

  • 7.1 By Product Type
    • 7.1.1 Condom
    • 7.1.2 Diaphragms
    • 7.1.3 Cervical Cap
    • 7.1.4 Vaginal Rings
    • 7.1.5 Intrauterine Device (IUD)
    • 7.1.6 Sub Dermal Contraceptive Implants
  • 7.2 By Gender
    • 7.2.1 Male Contraceptive Devices
    • 7.2.2 Female Contraceptive Devices
  • 7.3 By Distribution Channel
    • 7.3.1 Hospital Pharmacy
    • 7.3.2 Retail Pharmacy
    • 7.3.3 Online Pharmacies and D2C Platforms
    • 7.3.4 Hypermarkets and Supermarkets
    • 7.3.5 Others
  • 7.4 By Geography
    • 7.4.1 North America
      • 7.4.1.1 United States Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.1.2 Canada Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.1.3 Mexico Contraceptive Devices Market Size in USD million (2022-2032)
    • 7.4.2 Europe
      • 7.4.2.1 France Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.2 Germany Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.3 United Kingdom Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.4 Italy Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.5 Spain Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.2.6 Rest of Europe Contraceptive Devices Market Size in USD million (2022-2032)
    • 7.4.3 Asia-Pacific
      • 7.4.3.1 China Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.2 Japan Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.3 India Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.4 Australia Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.5 South Korea Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.3.6 Rest of Asia-Pacific Contraceptive Devices Market Size in USD million (2022-2032)
    • 7.4.4 Rest of the World (RoW)
      • 7.4.4.1 Middle East Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.4.2 Africa Contraceptive Devices Market Size in USD million (2022-2032)
      • 7.4.4.3 South America Contraceptive Devices Market Size In USD Million (2022-2032)

8. Competitive Landscape

9. Startup Funding & Investment Trends

10. Contraceptive Devices Market Company and Product Profiles

  • 10.1 Reckitt Benckiser Group PLC
    • 10.1.1 Company Overview
    • 10.1.2 Company Snapshot
    • 10.1.3 Financial Overview
    • 10.1.4 Product Listing
    • 10.1.5 Entropy
  • 10.2 Church & Dwight Co., Inc.
    • 10.2.1 Company Overview
    • 10.2.2 Company Snapshot
    • 10.2.3 Financial Overview
    • 10.2.4 Product Listing
    • 10.2.5 Entropy
  • 10.3 Organon & Co.
    • 10.3.1 Company Overview
    • 10.3.2 Company Snapshot
    • 10.3.3 Financial Overview
    • 10.3.4 Product Listing
    • 10.3.5 Entropy
  • 10.4 Bayer AG
    • 10.4.1 Company Overview
    • 10.4.2 Company Snapshot
    • 10.4.3 Financial Overview
    • 10.4.4 Product Listing
    • 10.4.5 Entropy
  • 10.5 CooperSurgical, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Company Snapshot
    • 10.5.3 Financial Overview
    • 10.5.4 Product Listing
    • 10.5.5 Entropy
  • 10.6 Mankind Pharma Ltd.
    • 10.6.1 Company Overview
    • 10.6.2 Company Snapshot
    • 10.6.3 Financial Overview
    • 10.6.4 Product Listing
    • 10.6.5 Entropy
  • 10.7 HLL Lifecare Limited
    • 10.7.1 Company Overview
    • 10.7.2 Company Snapshot
    • 10.7.3 Financial Overview
    • 10.7.4 Product Listing
    • 10.7.5 Entropy
  • 10.8 Karex Berhad
    • 10.8.1 Company Overview
    • 10.8.2 Company Snapshot
    • 10.8.3 Financial Overview
    • 10.8.4 Product Listing
    • 10.8.5 Entropy
  • 10.9 Okamoto Industries Inc.
    • 10.9.1 Company Overview
    • 10.9.2 Company Snapshot
    • 10.9.3 Financial Overview
    • 10.9.4 Product Listing
    • 10.9.5 Entropy
  • 10.10 Veru Inc.
    • 10.10.1 Company Overview
    • 10.10.2 Company Snapshot
    • 10.10.3 Financial Overview
    • 10.10.4 Product Listing
    • 10.10.5 Entropy
  • 10.11 Pregna International Limited
    • 10.11.1 Company Overview
    • 10.11.2 Company Snapshot
    • 10.11.3 Financial Overview
    • 10.11.4 Product Listing
    • 10.11.5 Entropy
  • 10.12 Kessel medintim GmbH
    • 10.12.1 Company Overview
    • 10.12.2 Company Snapshot
    • 10.12.3 Financial Overview
    • 10.12.4 Product Listing
    • 10.12.5 Entropy

11. KOL Views

12. Project Approach

13. About DelveInsight

14. Disclaimer & Contact Us

List of Tables

  • Table 1: Contraceptive Devices Market in Global (2022-2032)
  • Table 2: Contraceptive Devices Market in Global by Product Type (2022-2032)
  • Table 3: Contraceptive Devices Market in Global by Gender (2022-2032)
  • Table 4: Contraceptive Devices Market in Global by Distribution Channel (2022-2032)
  • Table 5: Contraceptive Devices Market in Global by Geography (2022-2032)
  • Table 6: Contraceptive Devices Market in North America (2022-2032)
  • Table 7: Contraceptive Devices Market in the United States (2022-2032)
  • Table 8: Contraceptive Devices Market in Canada (2022-2032)
  • Table 9: Contraceptive Devices Market in Mexico (2022-2032)
  • Table 10: Contraceptive Devices Market in Europe (2022-2032)
  • Table 11: Contraceptive Devices Market in France (2022-2032)
  • Table 12: Contraceptive Devices Market in Germany (2022-2032)
  • Table 13: Contraceptive Devices Market in United Kingdom (2022-2032)
  • Table 14: Contraceptive Devices Market in Italy (2022-2032)
  • Table 15: Contraceptive Devices Market in Spain (2022-2032)
  • Table 16: Contraceptive Devices Market in the Rest of Europe (2022-2032)
  • Table 17: Contraceptive Devices Market in Asia-Pacific (2022-2032)
  • Table 18: Contraceptive Devices Market in China (2022-2032)
  • Table 19: Contraceptive Devices Market in Japan (2022-2032)
  • Table 20: Contraceptive Devices Market in India (2022-2032)
  • Table 21: Contraceptive Devices Market in Australia (2022-2032)
  • Table 22: Contraceptive Devices Market in South Korea (2022-2032)
  • Table 23: Contraceptive Devices Market in Rest of Asia-Pacific (2022-2032)
  • Table 24: Contraceptive Devices Market in the Rest of the World (2022-2032)
  • Table 25: Contraceptive Devices Market in the Middle East (2022-2032)
  • Table 26: Contraceptive Devices Market in Africa (2022-2032)
  • Table 27: Contraceptive Devices Market in South America (2022-2032)
  • Table 28: Competitive Landscape
  • Table 29: Startup Funding & Investment Trends

List of Figures

  • Figure 1: Contraceptive Devices Market Drivers
  • Figure 2: Contraceptive Devices Market Restraints
  • Figure 3: Contraceptive Devices Market Opportunities
  • Figure 4: AI-Powered Innovations in the Contraceptive Devices Market
  • Figure 5: US Tariff Impact on Contraceptive Devices Market
  • Figure 6: Regulatory Analysis (US, EU, Japan, China)
  • Figure 7: Porter's Five Forces Analysis
  • Figure 8: Competitive Analysis
  • Figure 9: Contraceptive Devices Market in Global (2022-2032)
  • Figure 10: Contraceptive Devices Market in Global by Product Type (2022-2032)
  • Figure 11: Contraceptive Devices Market in Global by Gender (2022-2032)
  • Figure 12: Contraceptive Devices Market in Global by Distribution Channel (2022-2032)
  • Figure 13: Contraceptive Devices Market in Global by Geography (2022-2032)
  • Figure 14: Contraceptive Devices Market in North America (2022-2032)
  • Figure 15: Contraceptive Devices Market in the United States (2022-2032)
  • Figure 16: Contraceptive Devices Market in Canada (2022-2032)
  • Figure 17: Contraceptive Devices Market in Mexico (2022-2032)
  • Figure 18: Contraceptive Devices Market in Europe (2022-2032)
  • Figure 19: Contraceptive Devices Market in France (2022-2032)
  • Figure 20: Contraceptive Devices Market in Germany (2022-2032)
  • Figure 21: Contraceptive Devices Market in United Kingdom (2022-2032)
  • Figure 22: Contraceptive Devices Market in Italy (2022-2032)
  • Figure 23: Contraceptive Devices Market in Spain (2022-2032)
  • Figure 24: Contraceptive Devices Market in the Rest of Europe (2022-2032)
  • Figure 25: Contraceptive Devices Market in Asia-Pacific (2022-2032)
  • Figure 26: Contraceptive Devices Market in China (2022-2032)
  • Figure 27: Contraceptive Devices Market in Japan (2022-2032)
  • Figure 28: Contraceptive Devices Market in India (2022-2032)
  • Figure 29: Contraceptive Devices Market in Australia (2022-2032)
  • Figure 30: Contraceptive Devices Market in South Korea (2022-2032)
  • Figure 31: Contraceptive Devices Market in Rest of Asia-Pacific (2022-2032)
  • Figure 32: Contraceptive Devices Market in the Rest of the World (2022-2032)
  • Figure 33: Contraceptive Devices Market in the Middle East (2022-2032)
  • Figure 34: Contraceptive Devices Market in Africa (2022-2032)
  • Figure 35: Contraceptive Devices Market in South America (2022-2032)
  • Figure 36: Competitive Landscape
  • Figure 37: Startup Funding & Investment Trends